Wyden Cheers Beginning of Medicare Drug Price Negotiation

Announcement of First 10 Drugs to be Negotiated Marks Important Step Towards Lowering Prescription Drug Costs for Seniors

Washington, D.C. – Senate Finance Committee Chair Ron Wyden, D-Ore., today issued a statement after the Biden administration announced the ten prescription drugs covered by Medicare that will go through the negotiation process.

“Today marks the beginning of a new era for seniors and families that have been breaking the bank for far too long to pay for expensive prescription medicines,” Wyden said. “The products that will now be subject to negotiation are used by millions of seniors in Medicare each year, costing each of them thousands of dollars. This step, plus other cost saving measures in the Inflation Reduction Act, represent a seismic shift in the relationship between Big Pharma, the federal government, and seniors who are counting on lower prices. I will be following the negotiation process closely and will fight any attempt by Big Pharma to undo or undermine the progress that’s been made.”

###

Press Contact: Taylor Harvey

• Print
• Email
• Tweet